July 19, 2022 by Jeffrey Woldt
CVS Health, Jon Roberts
July 18, 2022, Leading Headlines, News
WOONSOCKET, R.I. — When asked about the high points of his professional life, Roberts, who retired as CVS Health’s chief operating officer at the end of June, cites three pivotal moments — the Pharmacy Services Initiative he led in 2000; the development and deployment in 2005 of RxConnect, the technology platform that still powers the
March 25, 2022 by Chain Drug Review
CVS, Jon Roberts
Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Jon Roberts will retire as chief operating officer of CVS Health in June, the company announced. CVS said that it does not plan to hire a new COO at the moment. A 42-year company veteran, Roberts has been COO since March 2017. Before that, he served as president of CVS Caremark, the
September 17, 2020 by Chain Drug Review
COVID-19 testing, CVS Health, Jon Roberts
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health said it plans to add more than 2,000 new COVID-19 drive-thru test sites at select CVS Pharmacy locations across the country to support the company’s ongoing efforts to increase access to testing and help slow the spread of the virus. The company also said it has administered three million COVID-19
July 16, 2020 by Chain Drug Review
COVID-19, CVS Health, Jon Roberts
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. —CVS Pharmacy has issued a face covering policy at all locations for customers. CVS Health chief operating officer Jon Roberts provided the following update on the use of face coverings at CVS Pharmacy locations: “Since the pandemic began, we’ve done everything we can to keep people safe and healthy. This includes requiring that store
July 3, 2019 by Chain Drug Review
CVS Health, CVS Pharmacy, drug disposal, Governor David Ige and the state legislature for enacting new legislation (HB-1272), Jon Roberts, Longs Drugs
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — As part of its commitment to helping build healthier communities, CVS Pharmacy on Tuesday applauded Governor David Ige and the state legislature for enacting new legislation (HB-1272) that will enable the installation of safe medication disposal units this month in many Longs Drugs locations across Hawaii. CVS Health and CVS Pharmacy operate Longs Drugs
June 6, 2018 by Chain Drug Review
Aetna, CVS Health, CVS Health-Aetna, David Denton, Dr. Alan M. Lotvin, Dr. Harold Paz, Dr. Troyen Brennan, Jon Roberts, Jr., Karen Lynch, Larry Merlo, Lisa Bisaccia, Mark Bertolini, Meg McCarthy, Richard di Benedetto, Rick Jelinek, Shawn Guertin, Steven Kelmar, Thomas Moriarty, Thomas Sabatino
Business, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has announced the management team that, following the close of the Aetna acquisition, will lead the combined company into the future. Aetna will operate as a stand-alone business unit within the CVS Health enterprise following the close and will be led by members of its current management team. In addition,
April 5, 2018 by Chain Drug Review
CVS Health, Jon Roberts, PBMs
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has reported that, in 2017, the company kept drug price growth nearly flat for its pharmacy benefit management (PBM) clients, at a minimal 0.2%, despite manufacturer price inflation near 10%. Overall, the combination of this nearly flat drug price growth, with low drug utilization growth of 1.7%, reduced drug trend
February 26, 2018 by Greg Jacobson and Chain Drug Review
CVS Health, CVS Pharmacy, Helena Foulkes, Hudson's Bay Co., Jon Roberts, Kevin Hourican, Lord & Taylor, Richard Baker, Saks Fifth Avenue
2018, Issue 02-26-2018, Issues, News
TORONTO — Helena Foulkes has been named chief executive officer of Hudson’s Bay Co. (HBC), an international department store and off-price retailer. The move brings to an end a 25-year career at CVS Health, where Foulkes most recently served as corporate executive vice president and president of CVS Pharmacy, the company’s retail pharmacy business. Following
November 6, 2017 by Geoff Walden and Chain Drug Review
Alex Gourlay, Anthem, CVS Caremark PBM, CVS Pharmacy, Express Scripts, Helena Foulkes, IngenioRx, Jon Roberts, Joseph Swedish, Larry Merlo, performance pharmacy network, pharmacy benefit management, Walgreens
2017, Issue 11-06-2017, Issues, News
WOONSOCKET, R.I. — CVS Health has announced two major agreements to boost pharmacy benefit management services. The company late last month introduced a 30,000-store performance-based pharmacy network anchored by CVS Pharmacy and Walgreens designed to deliver savings and improved clinical outcomes for CVS Caremark PBM members. That followed the company’s announcement of a five-year deal
October 24, 2017 by Chain Drug Review
Alex Gourlay, CVS Caremark performance-based network, CVS Health, CVS Pharmacy, Helena Foulkes, Jon Roberts, Walgreens
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — For its CVS Caremark pharmacy benefit manager, CVS Health next year plans to roll out a new 30,000-store pharmacy network anchored by CVS Pharmacy and Walgreens. CVS said late Tuesday that the performance-based network also will include up to 10,000 independent community pharmacies nationwide. Besides yielding unit cost savings, the CVS Caremark
August 19, 2017 by Geoff Walden and Chain Drug Review
CVS Health, Jon Roberts, Larry Merlo, medication adherence, Transform Diabetes Care
2017, Issue 08-21-2017, Issues, News
WOONSOCKET, R.I. — CVS Health plans to extend its Transform Diabetes Care initiative to four more disease states over the next two years. The program is expected to also cover asthma, hypertension, hypercholesterolemia and depression by midsummer 2019. Launched late last year, Transform Diabetes Care is designed to lower pharmacy costs through aggressive trend management
August 11, 2017 by Geoff Walden and Chain Drug Review
CVS Health, Jon Roberts, Larry Merlo, Transform Diabetes Care
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health plans to extend its Transform Diabetes Care initiative to four more disease states over the next two years. The program is expected to also cover asthma, hypertension, hypercholesterolemia and depression by midsummer 2019. Launched late last year, Transform Diabetes Care is designed to lower pharmacy costs through aggressive trend management
April 3, 2017 by Chain Drug Review
CVS Caremark, CVS Health, Doug Langa, Jon Roberts, Novo Nordisk, prescription savings program, Reduced Rx, Troy Brennan
2017, Issue 04-03-2017, Issues, News
WOONSOCKET, R.I. — CVS Health last month announced the launch of Reduced Rx, a prescription savings program offering discounts on certain medications directly to patients through the company’s pharmacy benefits manager, CVS Caremark. The announcement came a day after the company reported that prescription growth for CVS Caremark clients slowed in 2016 to its lowest
March 16, 2017 by Chain Drug Review
CVS Caremark, CVS Health, Doug Langa, Jon Roberts, Novo Nordisk, prescription drug savings program, Reduced Rx, Troy Brennan
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health plans to serve up discounts on certain medications via a new prescription drug savings program called Reduced Rx. CVS said Thursday that Reduced Rx is designed to help patients with high out-of-pocket costs afford vital medications. The discounts will be offered directly to patients through CVS Caremark, the company’s pharmacy benefit